Century Therapeutics (IPSC) Other Accumulated Expenses (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Other Accumulated Expenses data on file, last reported at $1.0 million in Q3 2025.

• Other Accumulated Expenses for Q3 2025 came in at $1.0 million, up 1132.14% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.0 million (up 1132.14% YoY), and the FY2024 annual result was $75000.0, up 167.86% from the prior year.
• Other Accumulated Expenses advanced to $1.0 million in Q3 2025 per IPSC's latest filing, from $49000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $1.0 million in Q3 2025 and troughed at $11000.0 in Q2 2023.
• A 4-year average of $164000.0 and a median of $75000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses slumped 88.14% in 2023, then soared 1132.14% in 2025.
• A 4-year view of Other Accumulated Expenses shows it stood at $236000.0 in 2022, then tumbled by 88.14% to $28000.0 in 2023, then jumped by 167.86% to $75000.0 in 2024, then jumped by 1280.0% to $1.0 million in 2025.
• Business Quant data shows IPSC's Other Accumulated Expenses at $1.0 million in Q3 2025, $49000.0 in Q2 2025, and $111000.0 in Q1 2025.